Clinical trial lead, University of Southampton
Appears in 1 story
Last updated Nov 6, 2026
Overseeing trial sites for the next phase
Thirty-nine healthy volunteers received the Cambridge vaccine and none had a serious side effect. Their blood carried antibodies that bound a wide range of sarbecoviruses, the family that includes SARS-CoV-2, the original SARS virus and related bat viruses. Neutralizing activity was modest and uneven.
Updated 5 days ago
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
